Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 276

1.

Liposomal amphotericin B therapy of murine histoplasmosis.

Graybill JR, Bocanegra R.

Antimicrob Agents Chemother. 1995 Aug;39(8):1885-7.

PMID:
7486941
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
[PubMed - indexed for MEDLINE]
3.

Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis.

Garcia A, Adler-Moore JP, Proffitt RT.

Antimicrob Agents Chemother. 2000 Sep;44(9):2327-32.

PMID:
10952575
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis.

Rodríguez-Arellanes G, Taylor ML, Pérez-Torres A, Curiel-Quesada E, Vargas-Mendoza CF, Martínez-Rivera MA.

Rev Invest Clin. 2009 Jan-Feb;61(1):4-10.

PMID:
19507469
[PubMed - indexed for MEDLINE]
5.

Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis.

Clemons KV, Lutz JE, Stevens DA.

Microbes Infect. 2001 Jan;3(1):3-10.

PMID:
11226849
[PubMed - indexed for MEDLINE]
6.

Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.

Poveda F, García-Alegría J, de las Nieves MA, Villar E, Montiel N, del Arco A.

Eur J Clin Microbiol Infect Dis. 1998 May;17(5):357-9.

PMID:
9721967
[PubMed - indexed for MEDLINE]
7.

Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Yardley V, Croft SL.

Antimicrob Agents Chemother. 1997 Apr;41(4):752-6.

PMID:
9087483
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.

Wheat LJ, Cloud G, Johnson PC, Connolly P, Goldman M, Le Monte A, Fuller DE, Davis TE, Hafner R; AIDS Clinical Trials Group; Mycoses Study Group of NIAID.

Antimicrob Agents Chemother. 2001 Aug;45(8):2354-7.

PMID:
11451696
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.

Khan MA, Owais M.

J Antimicrob Chemother. 2006 Jul;58(1):125-32. Epub 2006 May 18.

PMID:
16709592
[PubMed - indexed for MEDLINE]
Free Article
10.

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Ann Intern Med. 2002 Jul 16;137(2):105-9.

PMID:
12118965
[PubMed - indexed for MEDLINE]
11.

Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.

González GM, Tijerina R, Najvar LK, Bocanegra R, Rinaldi MG, Graybill JR.

Antimicrob Agents Chemother. 2004 Jun;48(6):2140-3.

PMID:
15155212
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.

Haynes RR, Connolly PA, Durkin MM, LeMonte AM, Smedema ML, Brizendine E, Wheat LJ.

J Infect Dis. 2002 Jun 15;185(12):1830-2. Epub 2002 May 31.

PMID:
12085335
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.

Khan MA, Nasti TH, Owais M.

J Antimicrob Chemother. 2005 Oct;56(4):726-31. Epub 2005 Aug 26.

PMID:
16126780
[PubMed - indexed for MEDLINE]
Free Article
15.

Case report. Successful therapy of disseminated histoplasmosis in AIDS with liposomal amphotericin B.

Rieg GK, Shah PM, Helm EB, Just-Nübling G.

Mycoses. 1999 Apr;42(1-2):117-20.

PMID:
10394860
[PubMed - indexed for MEDLINE]
16.

Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.

van Etten EW, ten Kate MT, Stearne LE, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1995 Sep;39(9):1954-8.

PMID:
8540697
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.

van Etten EW, van Vianen W, Hak J, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1998 Sep;42(9):2437-9.

PMID:
9736579
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.

Ortoneda M, Capilla J, Pujol I, Pastor FJ, Mayayo E, Fernández-Ballart J, Guarro J.

J Antimicrob Chemother. 2002 Mar;49(3):525-9.

PMID:
11864953
[PubMed - indexed for MEDLINE]
Free Article
19.

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Coukell AJ, Brogden RN.

Drugs. 1998 Apr;55(4):585-612. Review.

PMID:
9561346
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk